Douglas J. Warner - Aug 8, 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
Chief Medical Officer
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Douglas J. Warner
Stock symbol
EFTR
Transactions as of
Aug 8, 2022
Transactions value $
$0
Form type
4
Date filed
8/8/2022, 06:17 PM
Next filing
Jan 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFTR Stock Option (Right to Buy) Award $0 +618K $0.00 618K Aug 8, 2022 Common Stock 618K $0.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests 25% on August 8, 2023, and in 36 monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.